MD Anderson Cancer Center
Low forms of Cyclin E reduces drug's effectiveness
M. D. Anderson researchers find better way to predict prognosis in breast cancer patients treated with aromatase inhibitors; research also suggests a potential means of circumventing drug resistance
This video requires an updated Flash player. Please update your Flash player or watch on a device which supports Flash. Flash Player Help . For additional videos, please visit our online search for videos and podcasts.
Title: Low forms of Cyclin E reduces drug's effectiveness
Summary: M. D. Anderson researchers find better way to predict prognosis in breast cancer patients treated with aromatase inhibitors; research also suggests a potential means of circumventing drug resistance
Keywords: breast, cancer, cyclin e, aromatase inhibitor, drug resistance, Keyomarsi, MD Anderson, estrogen-receptor–positive, er+, low-molecular-weight, LMW-E
Transcript: